Della Pepa Giuseppe, Lombardi Gianluca, Gianfrancesco Salvatore, Piccolo Roberto, Chirico Giovanni, Pellegrino Micaela, Santella Luigi, Tecce Nicola, Volpicelli Anastasia, Sollo Elena, Bozzetto Lutgarda, Masulli Maria, Riccardi Gabriele, Rivellese Angela Albarosa, Saldalamacchia Gennaro
Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.
Cardiometabolic Risk Unit, Institute of Clinical Physiology, National Research Council-CNR, 56100 Pisa, Italy.
J Clin Med. 2023 May 22;12(10):3596. doi: 10.3390/jcm12103596.
The use of dressings is an essential component of the standard of care for diabetic foot ulcers (DFUs); however, despite the wide variety of dressings available, there is a lack of evidence from head-to-head randomized controlled trials. We evaluated the efficacy and safety of extract and polyhexanide (Fitostimoline hydrogel/Fitostimoline Plus gauze) versus saline gauze dressings in patients with DFUs.
This study involved a monocentric, two-arm, open-label, controlled trial in patients with DFUs (Grades I or II, Stage A or C, based on the Texas classification) randomized to 12 weeks of dressing with Fitostimoline hydrogel/Fitostimoline Plus gauze or saline gauze. The number of patients with complete healing, the reduction in DFU size, and the presence of local signs and symptoms of the wound and perilesional skin were evaluated every two weeks and at the end of treatment.
A total of 40 adult patients were recruited (20 patients in each treatment group). The proportion of patients with complete healing was similar between the two groups (61% vs. 74%, = 0.495, Fitostimoline hydrogel/Fitostimoline Plus gauze vs. saline gauze, respectively), without significant differences, as well as the reduction in DFU size. A significant improvement in local signs and symptoms of the wound and signs of perilesional skin in the Fitostimoline hydrogel/Fitostimoline Plus gauze compared with the saline gauze group was observed.
In a clinical setting, the use of Fitostimoline hydrogel/Fitostimoline Plus gauze dressing in patients with DFUs significantly improves signs and symptoms of the wound and signs of perilesional skin compared with saline gauze dressing with a similar efficacy in terms of wound healing.
敷料的使用是糖尿病足溃疡(DFU)标准治疗的重要组成部分;然而,尽管有各种各样的敷料,但缺乏来自直接比较的随机对照试验的证据。我们评估了提取物和聚己双胍(Fitostimoline水凝胶/Fitostimoline Plus纱布)与盐水纱布敷料对DFU患者的疗效和安全性。
本研究为单中心、双臂、开放标签的对照试验,纳入DFU患者(根据德克萨斯分类为I级或II级,A期或C期),随机分为两组,分别使用Fitostimoline水凝胶/Fitostimoline Plus纱布或盐水纱布进行为期12周的换药。每两周及治疗结束时评估完全愈合的患者数量、DFU大小的减小情况以及伤口和病灶周围皮肤的局部体征和症状。
共招募了40例成年患者(每个治疗组20例)。两组完全愈合的患者比例相似(分别为61%和74%,Fitostimoline水凝胶/Fitostimoline Plus纱布组与盐水纱布组相比,P = 0.495),DFU大小的减小情况也无显著差异。与盐水纱布组相比,观察到Fitostimoline水凝胶/Fitostimoline Plus纱布组伤口的局部体征和症状以及病灶周围皮肤体征有显著改善。
在临床环境中,与盐水纱布敷料相比,DFU患者使用Fitostimoline水凝胶/Fitostimoline Plus纱布敷料可显著改善伤口体征和症状以及病灶周围皮肤体征,在伤口愈合方面疗效相似。